PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that their partner, Norgine Pharmaceuticals Ltd., has launched PEDMARQSI ...

~ PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children ...

Then they found other humans who had been camping close by, leaving cigarette butts, litter – and two Fennec fox corpses. Yes, we humans might be the “most successful” mammals. But at what cost?

Weighing in at around 1kg, the fennec fox is the smallest of all the foxes. As a resident across the Sahara desert and other parts of North Africa the fennec’s long hairs may seem a bit out of ...

Editor's note: This is part of a series of videos offering an up-close perspective on the animal kingdom. A special 360-degree video camera system was set up in zoos and other facilities to show ...

In March 2024, Fennec entered into an exclusive licensing ... launches in other major European markets.” The data from two open-label, randomized Phase 3 trials, SIOPEL 6 (pivotal) and the ...